Paolo Bruzzi

1985–2023 年に発表

112
論文数
20,202
被引用数
85
h 指数
112
i10 指数

被引用数

Paolo Bruzzi の年別被引用数1982 年: 被引用 3 件1984 年: 被引用 1 件1986 年: 被引用 1 件1987 年: 被引用 1 件1988 年: 被引用 4 件1989 年: 被引用 9 件1990 年: 被引用 15 件1991 年: 被引用 15 件1992 年: 被引用 13 件1993 年: 被引用 17 件1994 年: 被引用 19 件1995 年: 被引用 23 件1996 年: 被引用 29 件1997 年: 被引用 41 件1998 年: 被引用 42 件1999 年: 被引用 52 件2000 年: 被引用 58 件2001 年: 被引用 67 件2002 年: 被引用 59 件2003 年: 被引用 85 件2004 年: 被引用 85 件2005 年: 被引用 79 件2006 年: 被引用 112 件2007 年: 被引用 99 件2008 年: 被引用 143 件2009 年: 被引用 162 件2010 年: 被引用 175 件2011 年: 被引用 173 件2012 年: 被引用 159 件2013 年: 被引用 157 件2014 年: 被引用 144 件2015 年: 被引用 153 件2016 年: 被引用 144 件2017 年: 被引用 146 件2018 年: 被引用 118 件2019 年: 被引用 460 件2020 年: 被引用 471 件2021 年: 被引用 602 件2022 年: 被引用 385 件2023 年: 被引用 235 件2024 年: 被引用 379 件2025 年: 被引用 154 件2026 年: 被引用 2 件1983 年は被引用が無いため表示していません1985 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,960 件、この内訳の 20.5%イタリア: 引用元論文 983 件、この内訳の 10.3%イギリス: 引用元論文 771 件、この内訳の 8.1%ドイツ: 引用元論文 549 件、この内訳の 5.7%フランス: 引用元論文 469 件、この内訳の 4.9%中国: 引用元論文 443 件、この内訳の 4.6%カナダ: 引用元論文 375 件、この内訳の 3.9%オランダ: 引用元論文 362 件、この内訳の 3.8%スペイン: 引用元論文 338 件、この内訳の 3.5%オーストラリア: 引用元論文 280 件、この内訳の 2.9%スイス: 引用元論文 243 件、この内訳の 2.5%ベルギー: 引用元論文 228 件、この内訳の 2.4%
0%20.5%その他 26.9%

分野

  • Medicine76%
  • Biochemistry, Genetics and Molecular Biology16%
  • Immunology and Microbiology2%
  • Health Professions1.5%
  • Mathematics0.7%
  • Engineering0.4%
  • その他3.4%

トピック

  • Breast Cancer Treatment Studies3.2%
  • Cardiomyopathy and Myosin Studies3%
  • COVID-19 Clinical Research Studies1.9%
  • Multiple Sclerosis Research Studies1.7%
  • Sarcoma Diagnosis and Treatment1.7%
  • Cancer Risks and Factors1.7%
  • その他86.8%

共著者

全論文

検索で開く
  1. Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christina Davies, Frances Duane, Vaughan Evans, Lucy Gettins, Jon Godwin, Robert K. Hills, Sam James, Hui Liu, Elizabeth MacKinnon, Gurdeep Mannu, Theresa McHugh, Philip Morris, Simon Read, Yaochen Wang, Zhe Wang, Peter A. Fasching, Nadia Harbeck, Pascal Piedbois, Michael Gnant, Guenther G. Steger, Angelo Di Leo, Stella Dolci, Prue Francis, Denis Larsimont, J.-M. Nogaret, C. Philippson, Martine Piccart, Sabine C. Linn, Petronella G.M. Peer, Vivianne C. G. Tjan‐Heijnen, S.B. Vliek, John R. Mackey, Dennis Slamon, John M.S. Bartlett, Vivien Bramwell, Bingshu E. Chen, Stephen Chia, Karen A. Gelmon, Paul E. Goss, Mark N. Levine, Wendy R. Parulekar, Joseph L. Pater, Eileen Rakovitch, Lois E. Shepherd, Dongsheng Tu, Timothy J. Whelan, Donald A. Berry, Gloria Broadwater, Constance Cirrincione, Hyman B. Muss, Raymond L. Weiss, Yi Shan, Yong fu Shao, Xiang Wang, Binghe Xu, Dongbing Zhao, Harry Bartelink, Nina Bijker, Jan Bogaerts, Fátima Cardoso, Tanja Čufer, Jean‐Pierre Julien, Philip Poortmans, Emiel J. Rutgers, Cornelis J.�H. van de Velde, Eva Carrasco, Miguel Ángel Seguí, Jens‐Uwe Blohmer, Serban Dan Costa, Bernd Gerber ほか 67 名 - The Lancet 2019 被引用: 394

  2. Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2020 被引用: 261

  3. Preservation of Axillary Lymph Nodes Compared with Complete Dissection in T1–2 Breast Cancer Patients Presenting One or Two Metastatic Sentinel Lymph Nodes: The SINODAR-ONE Multicenter Randomized Clinical Trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gaetano Castiglione, Simona Grossi, Maria Saveria Tavoletta, Camilla De Rossi, Annalisa Curcio, Daniele Friedman, Piero Fregatti, Carla Magni, Giovanni Tazzioli, Simona Papi, Riccardo Giovanazzi, Camelia Chifu, Rossella Bettini, Modestino Pezzella, Silvia Michieletto, Tania Saibene, Manuela Roncella, Matteo Ghilli, Andrea Sibilio, Anna Cariello, Saverio Coiro, Giuseppe Falco, Emanuele Zarba Meli, Lucio Fortunato, L. Ciuffreda, Roberto Murgo, Claudio Battaglia, Luca Rubino, Nicoletta Biglia, Valentina Elisabetta Bounous, Francesca Rovera, Corrado Chiappa, Giovanni Paolo Pollini, Sara Mirandola, Graziano Meneghini, Francesco Di Bartolo - Annals of Surgical Oncology 2022 被引用: 154

  4. Sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer patients undergoing mastectomy with one to two metastatic sentinel lymph nodes: sub-analysis of the SINODAR-ONE multicentre randomized clinical trial and reopening of enrolment

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Camilla De Rossi, Annalisa Curcio, Daniele Friedman, Piero Fregatti, Carla Magni, Giovanni Tazzioli, Simona Papi, Riccardo Giovanazzi, Camelia Chifu, Rossella Bettini, Modestino Pezzella, Silvia Michieletto, Tania Saibene, Manuela Roncella, Matteo Ghilli, Andrea Sibilio, Anna Cariello, Saverio Coiro, Giuseppe Falco, Emanuele Zarba Meli, Lucio Fortunato, L. Ciuffreda, Roberto Murgo, Claudio Battaglia, Luca Rubino, Nicoletta Biglia, Valentina Elisabetta Bounous, Francesca Rovera, Corrado Chiappa, Giovanni Paolo Pollini, Sara Mirandola, Graziano Meneghini, Francesco Di Bartolo, Oreste ­Gentilini - British journal of surgery 2023 被引用: 57

  5. Magnitude of Left Ventricular Hypertrophy and Risk of Sudden Death in Hypertrophic Cardiomyopathy

    著者: , , , , , - New England Journal of Medicine 2000 被引用: 1,139

  6. Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2017 被引用: 489

  7. Best practices for the management of local-regional recurrent chordoma: a position paper by the Chordoma Global Consensus Group

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Reiko Imai, Lee Jeys, Robin L. Jones, Bernd Kasper, Akira Kawai, Marco Krengli, A. Leithner, I. Logowska, Javier Martín‐Broto, Diego Mazzatenta, Carlo Morosi, P. Nicolai, O.J. Norum, Shreyaskumar Patel, Nicolas Penel, Piero Picci, S. Pilotti, Stefano Redaelli, F. Ricchini, Piotr Rutkowski, S. Scheipl, Chandranath Sen, E. Tamborini, Katherine A. Thornton, Beate Timmermann, Valter Torri, P.-U. Tunn, M. Uhl, Yoshiya Yamada, Damien C. Weber, D. Vanel, Péter Varga, Carmen Vleggeert‐Lankamp, Paolo G. Casali, J. Sommer - Annals of Oncology 2017 被引用: 243

  8. Extended therapy with letrozole as adjuvant treatment of postmenopausal patients with early-stage breast cancer: a multicentre, open-label, randomised, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2021 被引用: 86

  9. Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christopher P. Fox, Corrado Girmenia, Andreas H. Groll, Dag Heldal, Jannick Helweg Larsen, Raoul Herbrecht, Hans H. Hirsch, Elisabeth Johnson, G. A. Klyasova, Minna Koskuenvo, Katrien Lagrou, Russell E. Lewis, Per Ljungman, Johan Maertens, Georg Maschmeyer, Małgorzata Mikulska, Márcio Nucci, Christophe Padoin, Livio Pagano, Antonio Pagliuca, Zdeněk Ráčil, Patricia Ribaud, Christine Rinaldo, Valérie Rizzi Puechal, Emmanuel Roilides, Christine Robin, Montserrat Rovira, Markus Rupp, Sonia P. Sanchez, Peter Schellongowski, Petr Sedlacek, János Sinkó, Monica A. Slavin, Isabella Sousa Ferreira, Jan Styczyński, Frédéric Tissot, Claudio Viscoli, Katherine N. Ward, Anne‐Therese Witschi - Journal of Infection 2017 被引用: 196

  10. Pathologic Complete Response As a Potential Surrogate for the Clinical Outcome in Patients With Breast Cancer After Neoadjuvant Therapy: A Meta-Regression of 29 Randomized Prospective Studies

    著者: , , , , , , , , , - Journal of Clinical Oncology 2014 被引用: 242

  11. Neoadjuvant chemotherapy in high‐risk soft tissue sarcomas: A Sarculator‐based risk stratification analysis of the ISG‐STS 1001 randomized trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alessandro Gronchi - Cancer 2021 被引用: 101

  12. Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Paolo Luigi Colombelli, Andrea Angheben, Angelina Passaro, G Secondo, Renato Pascale, Ilaria Piazza, Nicola Facciolongo, Massimo Costantini, RCT-TCZ-COVID-19 Study Group - JAMA Internal Medicine 2020 被引用: 733

  13. Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I–II study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael Stadler, Evangelia Yannaki, Αthanasios Fassas, Αchilles Anagnostopoulos, Marco Bregni, Corrado Gallo Stampino, Paolo Bruzzi, Claudio Bordignon - The Lancet Oncology 2009 被引用: 484

  14. Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Svenja Nölting, Isabelle Bourdeau, Vasileios Chortis, Madeleine H. T. Ettaieb, Deborah Cosentini, Salvatore Grisanti, Eric Baudin, Paola Berchialla, Francesca Bovis, Maria Pia Sormani, Paolo Bruzzi, Felix Beuschlein, Jérôme Bertherat, Alfredo Berruti - The Lancet Diabetes & Endocrinology 2023 被引用: 75

  15. Syncope and Risk of Sudden Death in Hypertrophic Cardiomyopathy

    著者: , , , , , , , , , , , , , , - Circulation 2009 被引用: 366

  16. The prognostic importance of left ventricular outflow obstruction in hypertrophic cardiomyopathy varies in relation to the severity of symptoms

    著者: , , , , - Journal of the American College of Cardiology 2005 被引用: 263

  17. A randomized trial of adoptive immunotherapy with tumor-infiltrating lymphocytes and interleukin-2 versus standard therapy in the postoperative treatment of resected nonsmall cell lung cancer

    著者: , , , , , , , , , - Cancer 1996 被引用: 122

  18. A new prognostic and predictive tool for shared decision making in stage III colon cancer

    著者: , , , , , , , , , , - European Journal of Cancer 2020 被引用: 69

  19. Risk associated with pregnancy in hypertrophic cardiomyopathy

    著者: , , , , , , - Journal of the American College of Cardiology 2002 被引用: 198

  20. Implantable Cardioverter-Defibrillators and Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy

    著者: , , , , , , , , , , , , , , , , , , , , , - JAMA 2007 被引用: 800

  21. Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO)

    著者: , , , , , , , , , , , , - Blood 2001 被引用: 524

  22. Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: an open-label, 2 × 2 factorial, randomised phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2015 被引用: 201

  23. Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gianvito Martino, M. R. Rottoli, Claudio Solaro, Flavia Salvi, Alessandro Barilaro, Marco Capobianco - Multiple Sclerosis Journal 2011 被引用: 135

  24. ESTIMATING THE POPULATION ATTRIBUTABLE RISK FOR MULTIPLE RISK FACTORS USING CASE-CONTROL DATA

    著者: , , , , - American Journal of Epidemiology 1985 被引用: 1,242